Navigation path


Burden of resistance and disease in European nations
EC contribution
: € 1.139.412
: 36 months
Starting date
: 01/07/2007
Funding scheme
: N/A
: antimicrobial resistance, nosocomial infections, outcomes, hospital costs, European hospitals, infection control policies, cost-effectiveness, economic costs, economics of resistance, statistical methods
Contract/Grant agreement number
: 2005203
Project web-site


The emergence and spread of antimicrobial resistance (AMR) has become a major public health threat, and infections caused by antimicrobial resistant pathogens continue to increase in the European Union and worldwide. These infections cause suffering, incapacity and death, and impose an enormous financial burden on both healthcare systems and on society in general, because of direct costs due to prolongation of illness and treatment in hospital, indirect costs due to loss of productivity, and societal costs due to morbidity and mortality. This is likely to lead to already-scarce healthcare resources being diverted to infection control efforts, and will have long-term implications due to loss of confidence in the medical profession and in the public healthcare delivery system provided or regulated by governments. Therefore, the aim of this project is to provide realistic estimates of the burden of disease and the costs to societies attributable to infections caused by antimicrobial resistant pathogens in member states and accession countries of the European Union.

[+] Read More